German pharmaceuticals and crop protection group Bayer said on Wednesday it is targeting adjusted earnings of up to 10.1 billion euros ($11.7 billion) this year, when excluding the effect of currency swings.
In a statement, the company said 2026 earnings before interest, tax, depreciation and amortisation (EBITDA) before special items would likely come in between 9.6 billion euros and 10.1 billion euros, based on average exchange rates in 2025.
That compares with 9.67 billion euros it reported for 2025.
($1 = 0.8615 euros)
(Reporting by Ludwig Burger and Patricia Weiss)
